006280.KS KSC
GC Biopharma Corp.
1W: +2.0%
1M: -1.8%
3M: +1.4%
YTD: -25.6%
1Y: -6.5%
3Y: +13.3%
5Y: -60.5%
₩125,800.00 ($93.64)
-3500.00 (-2.71%)
Weekly Expected Move ±3.9%
₩115884
₩120842
₩125800
₩130758
₩135716
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#6
of 20
Medical - Pharmaceuticals
Technical Signal Map
5 Bullish
0 Neutral
8 Bearish
006280.KS
$1.4T
GC Biopharma Corp.
LEAN BEAR
-24
000250.KQ
$4.7T
Sam Chun Dang Pharm. Co., Ltd
BULLISH
+84
086450.KQ
$999B
DongKook Pharmaceutical Co., Ltd.
BULLISH
+62
009290.KS
$327B
Kwang Dong Pharmaceutical Co., Ltd.
BULLISH
+59
039200.KQ
$1.5T
Oscotec Inc.
BULLISH
+43
237690.KQ
$2.0T
ST Pharm Co.,Ltd.
LEAN BULL
+18
140410.KQ
$2.2T
Mezzion Pharma Co.,Ltd.
LEAN BEAR
-25
003850.KS
$715B
Boryung Corporation
BEARISH
-42
005250.KS
$552B
GC Corp.
BEARISH
-49
084110.KQ
$280B
Huons Global Co., Ltd.
BEARISH
-65
214450.KQ
$3.3T
PharmaResearch Co., Ltd.
BEARISH
-75
009420.KS
$2.5T
Hanall Biopharma Co., Ltd.
BEARISH
-75
185750.KS
$859B
Chong Kun Dang Pharmaceutical Corp.
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 006280.KS GC Biopharma Corp. | $1.4T | -28.8 | -4.0 | 1.7 | 0.5 | 9.7 | 6 | LEAN BEAR | -6.5 |
| 000250.KQ Sam Chun Dang Pharm. Co., Ltd | $4.7T | 271.4 | 6.3 | 6.0 | 6.0 | 20.8 | 6 | BULLISH | 13.2 |
| 086450.KQ DongKook Pharmaceutical Co., Ltd. | $999B | 13.4 | 11.5 | 12.9 | 6.8 | 12.7 | 7 | BULLISH | 22.5 |
| 009290.KS Kwang Dong Pharmaceutical Co., Ltd. | $327B | 13.0 | 3.6 | 3.1 | 0.6 | 5.5 | 3 | BULLISH | 7.9 |
| 039200.KQ Oscotec Inc. | $1.5T | 14.9 | 56.2 | 395.6 | 69.6 | 232.6 | 8 | BULLISH | 17.1 |
| 237690.KQ ST Pharm Co.,Ltd. | $2.0T | 25.2 | 13.6 | 12.1 | 12.1 | 29.6 | 7 | LEAN BULL | 4.5 |
| 140410.KQ Mezzion Pharma Co.,Ltd. | $2.2T | -75.2 | -68.3 | -68.4 | 349.2 | 6.9 | 2 | LEAN BEAR | 84.5 |
| 003850.KS Boryung Corporation | $715B | 5.9 | 14.4 | 5.2 | 8.6 | 4.0 | 5 | BEARISH | 0.1 |
| 005250.KS GC Corp. | $552B | -3.6 | -13.1 | 0.9 | 0.3 | 9.6 | 4 | BEARISH | -38.5 |
| 084110.KQ Huons Global Co., Ltd. | $280B | 12.2 | 4.1 | 8.7 | -0.4 | 4.1 | 6 | BEARISH | -52.8 |
| 214450.KQ PharmaResearch Co., Ltd. | $3.3T | 17.1 | 27.2 | 47.2 | 31.7 | 34.1 | 6 | BEARISH | -53.9 |
| 009420.KS Hanall Biopharma Co., Ltd. | $2.5T | -95.6 | -15.7 | 1.8 | -43.4 | 8.4 | 2 | BEARISH | 66.1 |
| 185750.KS Chong Kun Dang Pharmaceutical Corp. | $859B | 10.8 | 8.2 | 7.1 | 4.2 | 7.1 | 4 | BEARISH | -21.2 |
| 006280.KS GC Biopharma Corp. | $1.4T | -28.8 | -4.0 | 1.7 | 0.5 | 9.7 | 6 | LEAN BEAR | -6.5 |
| 000250.KQ Sam Chun Dang Pharm. Co., Ltd | $4.7T | 271.4 | 6.3 | 6.0 | 6.0 | 20.8 | 6 | BULLISH | 13.2 |
| 086450.KQ DongKook Pharmaceutical Co., Ltd. | $999B | 13.4 | 11.5 | 12.9 | 6.8 | 12.7 | 7 | BULLISH | 22.5 |
| 009290.KS Kwang Dong Pharmaceutical Co., Ltd. | $327B | 13.0 | 3.6 | 3.1 | 0.6 | 5.5 | 3 | BULLISH | 7.9 |
| 039200.KQ Oscotec Inc. | $1.5T | 14.9 | 56.2 | 395.6 | 69.6 | 232.6 | 8 | BULLISH | 17.1 |
| 237690.KQ ST Pharm Co.,Ltd. | $2.0T | 25.2 | 13.6 | 12.1 | 12.1 | 29.6 | 7 | LEAN BULL | 4.5 |
| 140410.KQ Mezzion Pharma Co.,Ltd. | $2.2T | -75.2 | -68.3 | -68.4 | 349.2 | 6.9 | 2 | LEAN BEAR | 84.5 |
| 003850.KS Boryung Corporation | $715B | 5.9 | 14.4 | 5.2 | 8.6 | 4.0 | 5 | BEARISH | 0.1 |
| 005250.KS GC Corp. | $552B | -3.6 | -13.1 | 0.9 | 0.3 | 9.6 | 4 | BEARISH | -38.5 |
| 084110.KQ Huons Global Co., Ltd. | $280B | 12.2 | 4.1 | 8.7 | -0.4 | 4.1 | 6 | BEARISH | -52.8 |
| 214450.KQ PharmaResearch Co., Ltd. | $3.3T | 17.1 | 27.2 | 47.2 | 31.7 | 34.1 | 6 | BEARISH | -53.9 |
| 009420.KS Hanall Biopharma Co., Ltd. | $2.5T | -95.6 | -15.7 | 1.8 | -43.4 | 8.4 | 2 | BEARISH | 66.1 |
| 185750.KS Chong Kun Dang Pharmaceutical Corp. | $859B | 10.8 | 8.2 | 7.1 | 4.2 | 7.1 | 4 | BEARISH | -21.2 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
006280.KS vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F